Invenomic Capital Management’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-460,514
| Closed | -$10.3M | – | 153 |
|
|
2024
Q2 | $10.3M | Buy |
+460,514
| New | +$10.3M | 0.5% | 67 |
|
|
2023
Q4 | – | Sell |
-526,458
| Closed | -$11.5M | – | 180 |
|
|
2023
Q3 | $11.5M | Sell |
526,458
-236,992
| -31% | -$5.18M | 0.48% | 65 |
|
|
2023
Q2 | $14.6M | Sell |
763,450
-629,259
| -45% | -$12M | 0.74% | 43 |
|
|
2023
Q1 | $27M | Buy |
1,392,709
+428,622
| +44% | +$8.32M | 1.53% | 18 |
|
|
2022
Q4 | $15.5M | Buy |
+964,087
| New | +$15.5M | 1.05% | 29 |
|